The asbestos-carbon nanotube analogy: An update
- PMID: 29960000
- PMCID: PMC6298811
- DOI: 10.1016/j.taap.2018.06.027
The asbestos-carbon nanotube analogy: An update
Abstract
Nanotechnology is an emerging industry based on commercialization of materials with one or more dimensions of 100 nm or less. Engineered nanomaterials are currently incorporated into thin films, porous materials, liquid suspensions, or filler/matrix nanocomposites with future applications predicted in energy and catalysis, microelectronics, environmental sensing and remediation, and nanomedicine. Carbon nanotubes are one-dimensional fibrous nanomaterials that physically resemble asbestos fibers. Toxicologic studies in rodents demonstrated that some types of carbon nanotubes can induce mesothelioma, and the World Health Organization evaluated long, rigid multiwall carbon nanotubes as possibly carcinogenic for humans in 2014. This review summarizes key physicochemical similarities and differences between asbestos fibers and carbon nanotubes. The "fiber pathogenicity paradigm" has been extended to include carbon nanotubes as well as other high-aspect-ratio fibrous nanomaterials including metallic nanowires. This paradigm identifies width, length, and biopersistence of high-aspect-ratio fibrous nanomaterials as critical determinants of lung disease, including mesothelioma, following inhalation. Based on recent theoretical modeling studies, a fourth factor, mechanical bending stiffness, will be considered as predictive of potential carcinogenicity. Novel three-dimensional lung tissue platforms provide an opportunity for in vitro screening of a wide range of high aspect ratio fibrous nanomaterials for potential lung toxicity prior to commercialization.
Keywords: Asbestos fibers; Carbon nanotubes; Fiber pathogenicity paradigm; High aspect ratio nanomaterials.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





References
-
- Akulian J, Yarmus L, Feller-Kopman D. The Evaluation and Clinical Application of Pleural Physiology. Clinics in Chest Medicine. 2013;34:11–19. - PubMed
-
- Arts JHE, Hadi M, Irfan MA, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Petry T, Sauer UG, Warheit D, Wiench K, Wohlleben W, Landsiedel R. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) Regulatory Toxicology and Pharmacology. 2015;71:S1–S27. - PubMed
-
- Arts JHE, Hadi M, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Petry T, Sauer UG, Warheit D, Wiench K, Landsiedel R. A critical appraisal of existing concepts for the grouping of nanomaterials. Regulatory Toxicology and Pharmacology. 2014;70:492–506. - PubMed
-
- Aschberger K, Johnston HJ, Stone V, Aitken RJ, Tran CL, Hankin SM, Peters SAK, Christensen FM. Review of fullerene toxicity and exposure – Appraisal of a human health risk assessment, based on open literature. Regulatory Toxicology and Pharmacology. 2010;58:455–473. - PubMed
-
- Boffetta P, Donaldson K, Moolgavkar S, Mandel JS. A systematic review of occupational exposure to synthetic vitreous fibers and mesothelioma. Critical Reviews in Toxicology. 2014;44:436–449. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical